Ascendis Pharma A/S (ASND)
209.87
+8.63
(+4.29%)
USD |
NASDAQ |
Dec 11, 16:00
209.87
0.00 (0.00%)
After-Hours: 16:39
Ascendis Pharma Profit Margin (Quarterly): -28.55% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Evaxion AS | -2.98K% |
| Novo Nordisk A/S | 26.68% |
| DBV Technologies SA | -- |
| Cellectis SA | 1.67% |
| Biodexa Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -20.57% |
| Return on Invested Capital | -34.40% |
| Gross Profit Margin (Quarterly) | 87.87% |
| Operating Margin (Quarterly) | 5.15% |
| Return on Net Operating Assets | -43.56% |